Intuitive Surgical, Inc. (NASDAQ:ISRG) – Investment analysts at Piper Jaffray Companies raised their Q4 2018 EPS estimates for Intuitive Surgical in a research note issued on Wednesday, January 9th. Piper Jaffray Companies analyst J. Mckim now forecasts that the medical equipment provider will earn $2.53 per share for the quarter, up from their previous forecast of $2.47. Piper Jaffray Companies has a “Overweight” rating and a $625.00 price target on the stock. Piper Jaffray Companies also issued estimates for Intuitive Surgical’s Q2 2019 earnings at $2.69 EPS and Q3 2019 earnings at $2.58 EPS.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.17. The firm had revenue of $920.90 million during the quarter, compared to analyst estimates of $916.22 million. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The company’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.77 EPS.
Other equities analysts have also issued reports about the stock. Citigroup reduced their target price on shares of Intuitive Surgical from $606.00 to $601.00 and set a “buy” rating for the company in a research note on Thursday, November 29th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $564.00 price target on the stock in a research report on Thursday, November 15th. Canaccord Genuity raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and boosted their price target for the stock from $550.00 to $610.00 in a research report on Friday, October 19th. They noted that the move was a valuation call. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $620.00 price target on shares of Intuitive Surgical in a research report on Friday, October 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $563.17.
Shares of NASDAQ ISRG opened at $518.07 on Friday. The firm has a market capitalization of $59.05 billion, a P/E ratio of 72.05, a P/E/G ratio of 3.44 and a beta of 1.07. Intuitive Surgical has a 1-year low of $380.00 and a 1-year high of $581.12.
A number of institutional investors have recently added to or reduced their stakes in the business. Cerebellum GP LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $260,000. Spence Asset Management raised its holdings in Intuitive Surgical by 3.7% in the 4th quarter. Spence Asset Management now owns 20,025 shares of the medical equipment provider’s stock valued at $9,590,000 after acquiring an additional 718 shares during the period. Moody National Bank Trust Division bought a new position in Intuitive Surgical in the 4th quarter valued at about $38,000. Tower View Investment Management & Research LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $920,000. Finally, Private Trust Co. NA grew its position in shares of Intuitive Surgical by 8.6% during the 4th quarter. Private Trust Co. NA now owns 692 shares of the medical equipment provider’s stock worth $331,000 after purchasing an additional 55 shares in the last quarter. 84.14% of the stock is currently owned by hedge funds and other institutional investors.
In other Intuitive Surgical news, EVP David J. Rosa sold 32,500 shares of the stock in a transaction dated Tuesday, October 23rd. The shares were sold at an average price of $500.86, for a total value of $16,277,950.00. Following the transaction, the executive vice president now directly owns 44,208 shares of the company’s stock, valued at approximately $22,142,018.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Salvatore Brogna sold 2,090 shares of the stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $541.88, for a total transaction of $1,132,529.20. Following the completion of the transaction, the chief operating officer now directly owns 2,049 shares in the company, valued at $1,110,312.12. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 72,491 shares of company stock worth $37,767,784. 2.20% of the stock is owned by insiders.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Further Reading: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.